The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study on the efficacy and safety of lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu: Positive advanced breast cancer (CECOG LaVie Trial).
 
Christiane Thallinger
No Relationships to Disclose
 
Istvan Lang
No Relationships to Disclose
 
Cvetka Grasic Kuhar
No Relationships to Disclose
 
Rupert Bartsch
Consulting or Advisory Role - GlaxoSmithKline
 
Christian F. Singer
No Relationships to Disclose
 
Lubos B. Petruzelka
No Relationships to Disclose
 
Bohuslav Melichar
Honoraria - GlaxoSmithKline; Novartis; Roche Pharma AG
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche Pharma AG
 
Regina Knittelfelder
No Relationships to Disclose
 
Thomas Brodowicz
No Relationships to Disclose
 
Christoph Zielinski
No Relationships to Disclose